Please ensure Javascript is enabled for purposes of website accessibility

Welcome to the Newest Dividend Aristocrats

By Dan Caplinger – Jan 17, 2013 at 9:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These companies' streaks of higher dividends hit 25 years.

Now more than ever, investors who need income from their portfolios have come to rely on dividend stocks. Because bonds, bank CDs, and other traditional sources of income have largely dried up, even more risk-averse investors have essentially found themselves forced to try to find the highest-quality dividend stocks they can buy.

One common way that prospective dividend investors seek to distinguish high-quality dividend stocks from the rest is by looking at S&P's list of Dividend Aristocrats. By meeting select criteria, the companies on the Dividend Aristocrats list have demonstrated their ability to stand the test of time, surviving through good times and bad to keep consistently rewarding their shareholders.

Yesterday, S&P made regular changes to its Dividend Aristocrats lists. I'll review those changes later in this article, but first, let's take a closer look at how a stock becomes a Dividend Aristocrat and why it's such a select group.

Stick with dividend royalty
The first thing to understand about Dividend Aristocrats is that membership in its broadest list has nothing at all to do with the most common way that ordinary investors judge dividend-paying stocks: their yield. It's easy to focus on high-yielding dividend stocks, but the problem with them is that even though their yields may be high right now, there's no guarantee that their payouts won't go away in the near future. Moreover, high yields often result from beaten-down shares, and despite the value opportunities that some of those stocks present, often, share-price declines turn out to be prescient in predicting dividend cuts.

By contrast, Dividend Aristocrats require a long track record of annual dividend increases. Historically, that threshold has been 25 years for all of the Dividend Aristocrats lists. Last summer, S&P reduced the requirement for its High Yield Dividend Aristocrats, which include not only S&P 500 companies but also the mid-cap and small-cap companies included in its broader S&P 1500 index, to 20 years. But the requirement for the main S&P 500 Dividend Aristocrats list remained at a quarter century.

Whether you look at 20 years or 25 years, the track-record requirement guarantees that companies have to demonstrate the ability to increase dividends even during tough times. The financial crisis of 2008 thinned the ranks of the Dividend Aristocrats considerably, as many stalwart financial companies that had previously maintained solid dividend growth found themselves having to eliminate or severely cut their payouts, breaking their streaks of increases.

The new Aristocrats
Reaching the 25-year mark for the first time this year are three S&P 500 companies: Chevron (CVX -2.47%), Cardinal Health (CAH -1.73%), and Pentair (PNR -3.00%). The companies have a diverse set of backgrounds, and the quality of their recent dividend increases varies widely.

For instance, Chevron has greatly accelerated the pace of payout hikes over the past two years. In 2011, the company raised its dividend twice, with the increase totaling 12.5%. In 2012, Chevron made another double-digit percentage dividend increase of 11%. Similarly, Cardinal has increased payouts at a 10%-plus annual pace since 2005. Pentair, on the other hand, has been satisfied with $0.01- and $0.02-per-share raises throughout its history, with the stingiest yield of the trio at just 1.7%.

Departing the Dividend Aristocrats is Pitney Bowes (PBI). The company didn't break its long streak of dividend increases, but its share price fell substantially enough that it triggered the requirement that a stock have a market cap of at least $3 billion to qualify. With an impressive yield of 12.8%, Pitney Bowes is still attractive to many dividend investors, but others believe that the company's plunging stock price reflects an inability to adapt to the near-demise of traditional mailing services.

Be careful out there
As Pitney Bowes' experience reveals, there's no guarantee that a Dividend Aristocrat will save you from big losses in your portfolio. But for the most part, the list is a good place to start your research in finding promising dividend stocks for your income portfolio.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Chevron. The Motley Fool owns shares of Pentair. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Chevron Stock Quote
Chevron
CVX
$176.56 (-2.47%) $-4.47
Pitney Bowes Stock Quote
Pitney Bowes
PBI
$3.95 (%)
Cardinal Health Stock Quote
Cardinal Health
CAH
$79.48 (-1.73%) $-1.40
Pentair Plc Stock Quote
Pentair Plc
PNR
$45.25 (-3.00%) $-1.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.